OpenURL Connection Search

Select item for more details and to access through your institution.

Continuous vs episodic prophylactic treatment with amiodarone for the prevention of atrial fibrillation: a randomized trial.
Published in:
2008
By:
- Ahmed S;
- Rienstra M;
- Crijns HJ;
- Links TP;
- Wiesfeld AC;
- Hillege HL;
- Bosker HA;
- Lok DJ;
- Van Veldhuisen DJ;
- Van Gelder IC;
- CONVERT Investigators;
- Ahmed, Sheba;
- Rienstra, Michiel;
- Crijns, Harry J G M;
- Links, Thera P;
- Wiesfeld, Ans C P;
- Hillege, Hans L;
- Bosker, Hans A;
- Lok, Dirk J A;
- Van Veldhuisen, Dirk J
Publication type:
journal article
Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes.
Published in:
2005
By:
- Brantsma AH;
- Bakker SJL;
- Hillege HL;
- De Zeeuw D;
- De Jong PE;
- Gansevoort RT;
- The PREVEND Study Group;
- Brantsma, Auke H;
- Bakker, Stephan J L;
- Hillege, Hans L;
- de Zeeuw, Dick;
- de Jong, Paul E;
- Gansevoort, Ronald T;
- PREVEND Study Group
Publication type:
journal article
The importance of whether atrial fibrillation or heart failure develops first.
Published in:
2012
By:
- Smit MD;
- Moes ML;
- Maass AH;
- Achekar ID;
- Van Geel PP;
- Hillege HL;
- van Veldhuisen DJ;
- Van Gelder IC
Publication type:
Journal Article
The COACH risk engine: a multistate model for predicting survival and hospitalization in patients with heart failure.
Published in:
2012
By:
- Postmus D;
- van Veldhuisen DJ;
- Jaarsma T;
- Luttik ML;
- Lassus J;
- Mebazaa A;
- Nieminen MS;
- Harjola VP;
- Lewsey J;
- Buskens E;
- Hillege HL
Publication type:
Journal Article
Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction.
Published in:
2011
By:
- Linssen GC;
- Rienstra M;
- Jaarsma T;
- Voors AA;
- van Gelder IC;
- Hillege HL;
- van Veldhuisen DJ
Publication type:
Journal Article
Effects of alagebrium, an advanced glycation endproduct breaker, on exercise tolerance and cardiac function in patients with chronic heart failure.
Published in:
2011
By:
- Hartog JW;
- Willemsen S;
- van Veldhuisen DJ;
- Posma JL;
- van Wijk LM;
- Hummel YM;
- Hillege HL;
- Voors AA;
- BENEFICIAL investigators
Publication type:
Journal Article
Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH)
Published in:
2009
By:
- Damman K;
- Jaarsma T;
- Voors AA;
- Navis G;
- Hillege HL;
- van Veldhuisen DJ;
- COACH Investigators
Publication type:
Journal Article
Determinants of depressive symptoms in hospitalised men and women with heart failure.
Published in:
2008
By:
- Lesman-Leegte I;
- Jaarsma T;
- Sanderman R;
- Hillege HL;
- van Veldhuisen DJ
Publication type:
Journal Article
The impact of depressive symptoms and quality of life in HF patients compared with community dwelling elderly.
Published in:
2007
By:
- Lesman-Leegte I;
- Jaarsma T;
- Sanderman R;
- Hillege HL;
- van Veldhuisen DJ
Publication type:
Journal Article
Anaemia and renal function independently associated with N-terminal pro B-type natriuretic peptide in patients hospitalised for heart failure: comparison with B-type natriuretic peptide.
Published in:
2006
By:
- Hogenhuis J;
- Voors AA;
- Jaarsma T;
- Hoes AW;
- Hillege HL;
- van Veldhuisen DJ
Publication type:
Journal Article
Incorporating patient preferences into drug development and regulatory decision making: Results from a quantitative pilot study with cancer patients, carers, and regulators.
Published in:
Clinical Pharmacology & Therapeutics, 2016, v. 99, n. 5, p. 548, doi. 10.1002/cpt.332
By:
- Postmus, D;
- Mavris, M;
- Hillege, HL;
- Salmonson, T;
- Ryll, B;
- Plate, A;
- Moulon, I;
- Eichler, H‐G;
- Bere, N;
- Pignatti, F
Publication type:
Article
Structured Frameworks to Increase the Transparency of the Assessment of Benefits and Risks of Medicines: Current Status and Possible Future Directions.
Published in:
Clinical Pharmacology & Therapeutics, 2015, v. 98, n. 5, p. 522, doi. 10.1002/cpt.203
By:
- Pignatti, F;
- Ashby, D;
- Brass, EP;
- Eichler, H‐G;
- Frey, P;
- Hillege, HL;
- Hori, A;
- Levitan, B;
- Liberti, L;
- Löfstedt, RE;
- McAuslane, N;
- Micaleff, A;
- Noel, RA;
- Postmus, D;
- Renn, O;
- Sabourin, BJ;
- Salmonson, T;
- Walker, S
Publication type:
Article
One risk assessment tool for cardiovascular disease, type 2 diabetes, and chronic kidney disease.
Published in:
2012
By:
- Alssema M;
- Newson RS;
- Bakker SJ;
- Stehouwer CD;
- Heymans MW;
- Nijpels G;
- Hillege HL;
- Hofman A;
- Witteman JC;
- Gansevoort RT;
- Dekker JM;
- Alssema, Marjan;
- Newson, Rachel S;
- Bakker, Stephan J L;
- Stehouwer, Coen D A;
- Heymans, Martijn W;
- Nijpels, Giel;
- Hillege, Hans L;
- Hofman, Albert;
- Witteman, Jacqueline C M
Publication type:
journal article
Current and novel renal biomarkers in heart failure.
Published in:
2012
By:
- Damman K;
- Voors AA;
- Navis G;
- van Veldhuisen DJ;
- Hillege HL;
- Damman, Kevin;
- Voors, Adriaan A;
- Navis, Gerjan;
- van Veldhuisen, Dirk J;
- Hillege, Hans L
Publication type:
journal article

Found: 14